Director-Affiliated Entity Sells $124.2M in UTI Stock
UTI sits 86% above its 52-week low of $21.29.
Summary
Coliseum Capital, an entity affiliated with a director, sold 3 million shares of Universal Technical Institute common stock for $124.2 million, significantly reducing its stake.
Key Events · Ownership and Investor Activity · UTI
-
Major Insider Sale
Coliseum Capital, an entity affiliated with a director, sold 3,000,000 shares of Universal Technical Institute common stock.
-
Significant Transaction Value
The open market sale totaled $124.2 million, executed at a price of $41.40 per share on June 8, 2026.
-
Substantial Stake Reduction
This transaction significantly reduced Coliseum Capital's holdings, leaving them with 971,440 shares post-sale.
Analysis · UTI · Trade & Services
Coliseum Capital, an entity affiliated with a director, executed a substantial block sale of Universal Technical Institute shares. This $124.2 million disposition, representing 5.675% of the company's market capitalization, indicates a significant reduction in their investment. Such a large sale by a director-affiliated institutional investor often signals a loss of conviction or a strategic portfolio rebalancing, especially given the substantial reduction in their overall holdings.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 39.9% of the 373 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.55%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UTI was trading at $39.55 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $21.29 to $45.74. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.